In this presentation, we answer five questions:
1. Why do we need to consider "future cells"?
2. What is SANB's role in "future cells"?
3. Where are we in the process of implementing the plan?
4. What are some of the current advanced therapies being applied to diseases in clinical trial situations?
5. "Future cells" approved for use of patients.